Back to search

Article

Gene therapy-mediated overexpression of wild-type MFN2 improves Charcot-Marie-Tooth disease type 2A

2025-10-15

Abstract excerpt

Charcot-Marie-Tooth disease type 2A (CMT2A) is the most common axonal CMT and is associated with an early onset and severe motor-dominant phenotype. CMT2A is mainly caused by dominant mutations in the MFN2 gene, encoding Mitofusin-2, a GTPase located in the outer membrane of the mitochondria and endoplasmic reticulum (ER). Mutations in MFN2 are known to affect mitochondrial dynamics. We previously demonstrated t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
944e851a-47f4-5cd4-a558-6430b38a0d57
DOI
10.1101/2025.10.15.682364
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gene therapy-mediated overexpression of wild-type MFN2 improves Charcot-Marie-Tooth disease type 2ADOI 10.1101/2025.10.15.682364
Select a neighboring publication to make it the new centre.